Spectro Scientific, one of the world’s largest suppliers of oil, fuel, and processed-water analysis instrumentation and software, has released a new generation of its field-proven FluidScan® mid-infrared spectrometer handheld oil analyzer. Patented FluidScan technology collects light transmitted through one drop of a fluid sample and registers the infrared absorption spectrum. The analyzer compares spectrum data to a built-in fluid [...]

Stratedigm is reinventing the way you design your automation experiments. With CellCapTure’s optional patent pending Visual Protocol Designer (VPD), users can easily create complex tasks and protocols to fully automate their experiments by utilizing a visual, drag-and-drop system. By utilizing “action blocks” for mixing, incubating, recording, and pipetting from well to well, users can now create novel [...]

Senior Financial Leader with Broad Corporate and Biotech Expertise SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of Laura M. Clague to the company’s Board of Directors and its audit committee. Clague is Chief Financial Officer of Retrophin, Inc., with more than 30 years of experience as a senior financial executive. Clague has served as CFO [...]

SAN ANTONIO, TX and HAYWARD, CA - Paragon Genomics, Inc., a leader in amplicon-based target enrichment and library preparation solutions for next-generation sequencing (NGS) assays today announced a partnership with SOPHiA GENETICS designed to accelerate the global adoption of Data-Driven Medicine worldwide. Under the terms of the agreement, Paragon Genomics’ CleanPlex® NGStarget enrichment technologies will be [...]

SAN DIEGOT Allele Biotechnology & Pharmaceuticals Inc. has received issuance notices from the U.S. Patent and Trademark Office for its first batch of patents covering the derivation of induced pluripotent stem cells (iPSCs). Allele’s proprietary technology uses only messenger RNA (mRNA) to reprogram human or other primate cells, avoiding many operational complications that other methods [...]

Agilent OnePGT solution empowers fertility specialists to attain comprehensive insights to improve the ranking of in vitro fertilized (IVF) embryos SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced the introduction of Agilent OnePGT, a genome-wide, next-generation sequencing (NGS) solution for preimplantation genetic testing (PGT). OnePGT allows parallel detection of multiple monogenic disorders (PGT-M), [...]

Expands Database for Detection of Sugar Syrups and Verification of Geographical and Botanical Origin SHANGHAI, China - At the Analytica China 2018 (www.analyticachina.com), Bruker today announced the release of its proprietary Honey-Profiling 2.0 method for the NMR FoodScreener® platform, which has been granted ISO/IEC 17025 accreditation already in 2015. The new method was developed in collaboration with partners QSI and [...]

COLOGNE, Germany & LEIDEN, Netherlands & CAMBRIDGE, England--Ncardia, a leader in human iPSC-based solutions for drug safety and efficacy screening, and Horizon Discovery Group plc (LSE:HZD) (Horizon), a global leader in gene editing and gene modulation technologies, announced a partnership to provide custom genetically modified and differentiated human iPSC-derived cells (hiPSC) for drug discovery researchers. [...]

AMSBIO has expanded its range of high quality FFPE cancer cell line controls for immunohistochemistry (IHC), in situ hybridization (ISH) and Next Generation Sequencing (NGS) applications. Variations in FFPE tissue sample quality and experimental setup can lead to misleading results without reliable controls. Traditional cell or tissue-based control specimens often present intra specimen variation, lot-to-lot variations [...]

SAN DIEGO-- Illumina, Inc. (NASDAQ: ILMN) today announces the launch of TruSightTM Oncology 500 (TSO 500), a comprehensive pan-cancer assay designed to identify known and emerging tumor biomarkers. TruSight Oncology 500 utilizes both DNA and RNA from subject tumor samples to identify key somatic variants underlying tumor progression, such as small DNA variants, fusions, and splice variants. Importantly, [...]